Treatment of amelanotic choroidal melanoma with photodynamic therapy

Retina

Volumn 32, Issue 7, 2012, Pages 1356-1362

  Campbell, William G ^a   Pejnovic, Tanya M ^a  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

amelanotic choroidal melanoma; photodynamic therapy; verteporfin

Indexed keywords

PREDNEFRIN; PREDNISOLONE; VERTEPORFIN;

ADULT; AGED; AMELANOTIC MELANOMA; ARTICLE; B SCAN; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CHOROID MELANOMA; CLINICAL ARTICLE; CLINICAL EXAMINATION; DRUG EFFECT; EYE DISCOMFORT; EYE PAIN; EYE PHOTOGRAPHY; FEMALE; HUMAN; LIVER METASTASIS; MALE; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; TREATMENT RESPONSE;

ADULT; AGED; CHOROID NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA, AMELANOTIC; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TREATMENT OUTCOME;

EID: 84862891100     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.10.1097/IAE.0b013e31822c28ec     Document Type: Article

References (27)

1. Damato B, Kacperek A, Chopra M, et al. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 2005;62:1405-1411. (Pubitemid 40982062)
2. Dieckmann K, Georg D, Zehetmayer M, et al. LINAC based stereotactic radiotherapy of uveal melanoma. Radiother Oncol 2003;67:199-206.
3. Damato B, Patel I, Campbell IR, et al. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas. Int J Radiat Oncol Biol Phys 2005;63:392-400. (Pubitemid 41317155)
4. Bergman L, Nilsson B, Lundell G, et al. Ruthenium brachy-therapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Ophthalmology 2005;112:834-840. (Pubitemid 40631502)
5. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome on 1106 consecutive patients. Arch Ophthalmol 2000;118:1219-1228.
6. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2002 Dec;109:2197-2206. (Pubitemid 35417099)
7. Harbour JW, Meredith TA, Thompson PA, Gordon ME. Trans-pupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas. Ophthalmology 2003;110:2207-2214. (Pubitemid 37337860)
8. Shields CL, Shields JA, Perez N, et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology 2002; 109:225-234. (Pubitemid 34106023)
9. Spire M, Devouassoux MS, Kodjikian L, et al. Primary trans-pupillary thermotherapy for 18 small posterior pole uveal melanomas. Am J Ophthalmol 2006;141:840-849.
10. Aarberg TM Jr, Bergstrom CS, Hickner ZJ, Lynn MJ. Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma. Br J Ophthalmol 2008;92: 741-746. (Pubitemid 351839560)
11. Dougherty T, Lawrence G, Kaufman J, et al. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979;62:231-237. (Pubitemid 9094709)
12. Dougherty T. Photosensitization of malignant tumours. Semin Surg Oncol 1986;2:24-37.
13. Schmidt-Erfurth U, Bauman W, Gragoudas E, et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology 1994;101:89-99. (Pubitemid 24044148)
14. Kim RY, Hu LK, Foster BS, et al. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology 1996;103:2029-2036. (Pubitemid 27024623)
15. Barbazetto IA, Lee TC, Rollins IS, et al. Treatment of choroi-dal melanoma using photodynamic therapy. Am J Ophthalmol 2003;135:898-899. (Pubitemid 36677415)
16. Favilla I, Barry WR, Gosbell A, et al. Phototherapy of posterior uveal melanomas. Br J Ophthalmol 1991;75:718-721.
17. Favilla I, Favilla AD, Gosbell WR, et al. Photodynamic therapy: a 5 year study of its effectiveness in the treatment of posterior uveal melanoma, and evaluation of haematoporphyrin uptake and photocytotoxicity of melanoma cells in tissue culture. Melanoma Res 1995;5:355-364.
18. Bruce RA Jr. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas. Lasers Surg Med 1984;4:59-64. (Pubitemid 14055658)
19. Wachtlin J, Bechrakis NE, Foerster MH. Photodynamic therapy with verteporfin for uveal melanoma. Ophthalmologe 2005;102:241-246.
20. Soucek P, Cihelkova I. Photodynamic therapy with verteporfin in subfoveal amelanotic choroidal melanoma. Neuro Endocri-nol Lett 2006;27:145-148. (Pubitemid 43970783)
21. Azab M, Benchaboune M, Blinder KJ, et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Ver-teporfin In Photodynamic Therapy Study Report no. 4. Retina 2004;24:1-12.
22. Singh AD, Kaiser PK, Sears JE, et al. Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol 2004; 88:1414-1418. (Pubitemid 39424721)
23. Michels S, Michels R, Simander C, Schmidt-Erfurth U. Verte-porfin therapy for choroidal hemangioma: a long-term follow-up. Retina 2005;25:697-703. (Pubitemid 41254538)
24. Vicuna-Kojchen J, Banin E, Averbukh E, et al. Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma. Ophthalmologica 2006; 220:351-355. (Pubitemid 44725969)
25. Donaldson MJ, Lim L, Harper A, et al. Primary treatment of choroidal amelanotic melanoma with photodynamic therapy. Clin Experiment Ophthalmol 2005;33:548-549. (Pubitemid 44056425)
26. Straatsma BR, Fine SL, Earle JD, et al. The Collaborative Ocular Melanoma Study Research Group. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 1988;95:1000-1004.
27. Young LH, Howard MA, Hu LK, et al. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Invest Ophthalmol Vis Sci 1995;36:871-878.